PROX1 Blocking Peptide – Cat# MBS9627470

PROX1 Blocking Peptide – The purity is >90%,tested by HPLC and MS. Purity

Name: PROX1 Blocking Peptide; The purity is >90%,tested by HPLC and MS. Purity; MyBioSource
Brand: MyBioSource
SKU: MBS9627470
Price: 460 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9627470

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the… More details

$460 / 1 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

PROX1, Blocking Peptide

Full Product Name

PROX1 Blocking Peptide

Product Gene Name

PROX1 blocking peptide

Product Synonym Names

Homeobox prospero like protein; Homeobox prospero like protein PROX1; Homeobox prospero-like protein PROX1; Prospero homeobox 1; Prospero homeobox protein 1; Prospero related homeobox 1; prospero-related homeobox gene 1; PROX 1; PROX-1; PROX1; PROX1_HUMAN; zgc:111888

Form/Format

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.

Purity/Purification

The purity is >90%,tested by HPLC and MS.

Preparation and Storage

Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.

Antibody/Peptide Pairs

PROX1 peptide (MBS9627470) is used for blocking the activity of PROX1 antibody (MBS9608758)

Molecular Weight

83203 MW

OMIM

601546

Supply Chain Verification

Manufactured in a lab with traceable raw materials manufactured on site. Coordinated product portfolio of antibodies, pairs, conjugates, recombinant proteins, and immunoassay materials available, please inquire.

Notes

For phospho antibody, we provide phospho peptide (0.5mg) and non-phospho peptide (0.5mg)

ISO Certification

Manufactured in an ISO 9001:2015 Certified Laboratory.

Applications Tested/Suitable for PROX1 blocking peptide

Blocking/Control

Other Notes

Small volumes of PROX1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for PROX1 purchase

MBS9627470 is a blocking peptide targeting PROX1.

Additional Details

NCBI/Uniprot data below describe general gene information for PROX1. It may not necessarily be applicable to this product.

NCBI GI #

397174762

NCBI GeneID

5629

NCBI Accession #

NP_001257545.1

UniProt Primary Accession #

Q92786

UniProt Secondary Accession #

Q5SW76; Q8TB91; A6NK29; A8K2B1

UniProt Related Accession #

Q92786

GenBank Nucleotide #

NM_001270616.1

NCBI Official Full Name

prospero homeobox protein 1

UniProt Protein Name

Prospero homeobox protein 1

UniProt Synonym Protein Names

Homeobox prospero-like protein PROX1; PROX-1

Protein Family

Prospero homeobox protein

UniProt Gene Name

PROX1

UniProt Synonym Gene Names

PROX-1

UniProt Entry Name

PROX1_HUMAN

UniProt Comments for PROX1

PROX1: May play a fundamental role in early development of CNS. May regulate gene expression and development of postmitotic undifferentiated young neurons. Belongs to the Prospero homeobox family.

Protein type: DNA-binding; Transcription factor; Nuclear receptor co-regulator

Chromosomal Location of Human Ortholog: 1q41

Cellular Component: cytoplasm; nucleus

Molecular Function: RNA polymerase II transcription factor activity, enhancer binding; ligand-dependent nuclear receptor binding; protein binding; DBD domain binding; DNA binding; LBD domain binding; transcription factor activity; transcription corepressor activity

Biological Process: transcription from RNA polymerase II promoter; lens development in camera-type eye; circadian rhythm; neural tube development; positive regulation of cyclin-dependent protein kinase activity; ventricular cardiac myofibril development; muscle thin filament assembly; atrial cardiac muscle morphogenesis; positive regulation of transcription, DNA-dependent; cell fate determination; negative regulation of transcription from RNA polymerase II promoter; olfactory placode formation; negative regulation of cell proliferation; venous blood vessel morphogenesis; pancreas development; positive regulation of cell proliferation; lymphangiogenesis; ventricular cardiac muscle morphogenesis; kidney development; response to nutrient levels; dentate gyrus development; negative regulation of transcription factor activity; positive regulation of cell cycle; liver development; regulation of circadian rhythm; cerebellar granule cell differentiation; dorsal spinal cord development; negative regulation of viral genome replication; regulation of gene expression; otic placode formation; embryonic retina morphogenesis in camera-type eye; positive regulation of endothelial cell proliferation; optic placode formation involved in camera-type eye; positive regulation of transcription from RNA polymerase II promoter; brain development; negative regulation of transcription, DNA-dependent; retina morphogenesis in camera-type eye; lung development

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with PROX1 blocking peptide

Reference Product	PubMed Publications
PAX6 blocking peptide	>42 publications with PROX1 and PAX6
SOX18 blocking peptide	>9 publications with PROX1 and SOX18
NOTCH1 blocking peptide	>8 publications with PROX1 and NOTCH1
NR5A2 blocking peptide	>7 publications with PROX1 and NR5A2
ATOH1 blocking peptide	>7 publications with PROX1 and ATOH1
FOXN4 blocking peptide	>4 publications with PROX1 and FOXN4
PCNA blocking peptide	>3 publications with PROX1 and PCNA
HOXD8 blocking peptide	>1 publications with PROX1 and HOXD8

Diseases associated with PROX1 blocking peptide

Disease Name	Pubmed Publications
Neoplasms Antibodies	>62 publications with PROX1 and Neoplasms
Neoplasm Metastasis Antibodies	>16 publications with PROX1 and Neoplasm Metastasis
Brain Diseases Antibodies	>14 publications with PROX1 and Brain Diseases
Inflammation Antibodies	>14 publications with PROX1 and Inflammation
Liver Diseases Antibodies	>12 publications with PROX1 and Liver Diseases
Liver Neoplasms Antibodies	>10 publications with PROX1 and Liver Neoplasms
Carcinoma, Hepatocellular Antibodies	>7 publications with PROX1 and Carcinoma, Hepatocellular
Diabetes Mellitus, Type 2 Antibodies	>7 publications with PROX1 and Diabetes Mellitus, Type 2
Neoplasms, Experimental Antibodies	>5 publications with PROX1 and Neoplasms, Experimental
Heart Diseases Antibodies	>5 publications with PROX1 and Heart Diseases

Organs/Tissues associated with PROX1 blocking peptide

Organ/Tissue Name	Pubmed Publications
Embryonic Tissue Antibodies	>76 publications with PROX1 and Embryonic Tissue
Eye Antibodies	>75 publications with PROX1 and Eye
Brain Antibodies	>45 publications with PROX1 and Brain
Liver Antibodies	>44 publications with PROX1 and Liver
Muscle Antibodies	>22 publications with PROX1 and Muscle
Lymph Node Antibodies	>18 publications with PROX1 and Lymph Node
Lung Antibodies	>12 publications with PROX1 and Lung
Intestine Antibodies	>4 publications with PROX1 and Intestine
Connective Tissue Antibodies	>3 publications with PROX1 and Connective Tissue
Testis Antibodies	>3 publications with PROX1 and Testis